![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif)
Prostate Cancer ScreeningWhat Family Physicians Believe Is Best
Ronald J. Hicks, MD;
Robert M. Hamm, PhD;
Debra A. Bemben, PhD
Arch Fam Med. 1995;4(4):317-322.
Abstract
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) | ![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
Objective To determine current family physician beliefs concerning prostate cancer screening.
Design Two hundred eighty-six Oklahoma family physicians were surveyed by mail. Fifty-three percent of physicians returned the questionnaire. Physicians were questioned on what tests they order for prostate screening, the reasons for ordering a serum prostate-specific antigen (PSA) test, what test results would cause a urologic referral for further evaluation of prostate cancer, and whether prostate cancer screening would decrease the patient's mortality or improve quality of life.
Results Most physicians (74%) believed that both a digital rectal examination and a serum PSA determination are appropriate for prostate cancer screening. Physicians' primary reasons for ordering a PSA test were to decrease patient mortality and morbidity. Sixty-two percent of physicians believed that prostate cancer screening would decrease mortality and 69% agreed that screening would improve quality of life. Approximately 90% of physicians would refer patients with a PSA level greater than 12 µg/L or a PSA level of 5 µg/L and an indurated prostate. Significant variation was found between groups of physicians in their beliefs about prostate cancer screening.
Conclusion Although the literature has been inconclusive on the benefit of prostate cancer screening, the majority of Oklahoma family physicians would choose to screen their patients and believe that patients' mortality and morbidity are decreased by early identification of prostate cancer.
Author Affiliations
From the Program in Clinical Decision Making, Department of Family Medicine, Oklahoma University Health Sciences Center, Oklahoma City.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Effect of Guidelines on Primary Care Physician Use of PSA Screening: Results from the Community Tracking Study Physician Survey
Guerra et al.
Med Decis Making 2008;28:681-689.
ABSTRACT
Why do Primary Care Physicians in the United States and France Order Prostate-Specific Antigen Tests for Asymptomatic Patients?
Sorum et al.
Med Decis Making 2003;23:301-313.
ABSTRACT
Determinants of Prostate-Specific Antigen Test Use in Prostate Cancer Screening by Primary Care Physicians
Austin et al.
Arch Fam Med 1997;6:453-458.
ABSTRACT
Screening for Prostate Cancer with Prostate-Specific Antigen -- An Examination of the Evidence
Woolf
NEJM 1995;333:1401-1405.
FULL TEXT
Prostate Cancer Screening
Thompson
Arch Fam Med 1995;4:307-308.
ABSTRACT
|